ASX - By Stock
|
PAB |
Re:
Ann: Positive preclinical data for deoxymabs in vasculitis
|
|
salty74
|
12 |
5.1K |
2 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
12
|
5.1K
|
2
|
|
ASX - By Stock
|
BML |
Re:
Ann: Letter to Eligible Entitlement Offer Shareholders
|
|
salty74
|
11 |
3.2K |
5 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
11
|
3.2K
|
5
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 31 March 2024
|
|
salty74
|
30 |
10K |
11 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
30
|
10K
|
11
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 31 March 2024
|
|
salty74
|
30 |
10K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
30
|
10K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Presentation to highlight broader potential of Deoxymabs
|
|
salty74
|
89 |
33K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
89
|
33K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Presentation to highlight broader potential of Deoxymabs
|
|
salty74
|
89 |
33K |
4 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
89
|
33K
|
4
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Positive preclinical data for deoxymabs in vasculitis
|
|
salty74
|
12 |
5.1K |
7 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
12
|
5.1K
|
7
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Presentation to highlight broader potential of Deoxymabs
|
|
salty74
|
89 |
33K |
2 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
89
|
33K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Presentation to highlight broader potential of Deoxymabs
|
|
salty74
|
89 |
33K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
89
|
33K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Presentation to highlight broader potential of Deoxymabs
|
|
salty74
|
89 |
33K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
89
|
33K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Presentation to highlight broader potential of Deoxymabs
|
|
salty74
|
89 |
33K |
1 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
89
|
33K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Presentation to highlight broader potential of Deoxymabs
|
|
salty74
|
89 |
33K |
1 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
89
|
33K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Presentation to highlight broader potential of Deoxymabs
|
|
salty74
|
89 |
33K |
1 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
89
|
33K
|
1
|
|
ASX - By Stock
|
LYC |
Re:
Interesting
|
|
salty74
|
149 |
60K |
22 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
149
|
60K
|
22
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Presentation to highlight broader potential of Deoxymabs
|
|
salty74
|
89 |
33K |
7 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
89
|
33K
|
7
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4D - Half Year Accounts - 31 December 2023
|
|
salty74
|
10 |
4.2K |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
10
|
4.2K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4D - Half Year Accounts - 31 December 2023
|
|
salty74
|
10 |
4.2K |
3 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
10
|
4.2K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4D - Half Year Accounts - 31 December 2023
|
|
salty74
|
10 |
4.2K |
2 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
10
|
4.2K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
2024 An Eventful Year
|
|
salty74
|
61 |
24K |
10 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
61
|
24K
|
10
|
|
ASX - By Stock
|
PAB |
Re:
2024 An Eventful Year
|
|
salty74
|
61 |
24K |
2 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
61
|
24K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
2024 An Eventful Year
|
|
salty74
|
61 |
24K |
5 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
61
|
24K
|
5
|
|
ASX - By Stock
|
PAB |
Re:
2024 An Eventful Year
|
|
salty74
|
61 |
24K |
3 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
61
|
24K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Chair's Address and CEO Presentation to 2023 AGM
|
|
salty74
|
74 |
27K |
4 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
74
|
27K
|
4
|
|
ASX - By Stock
|
PAB |
Re:
2024 An Eventful Year
|
|
salty74
|
61 |
24K |
5 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
61
|
24K
|
5
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Chair's Address and CEO Presentation to 2023 AGM
|
|
salty74
|
74 |
27K |
1 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
74
|
27K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: GMP Production of PAT-DX1 Next Quarter
|
|
salty74
|
62 |
14K |
0 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
62
|
14K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: GMP Production of PAT-DX1 Next Quarter
|
|
salty74
|
62 |
14K |
2 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
62
|
14K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: GMP Production of PAT-DX1 Next Quarter
|
|
salty74
|
62 |
14K |
0 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
62
|
14K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: GMP Production of PAT-DX1 Next Quarter
|
|
salty74
|
62 |
14K |
2 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
62
|
14K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: GMP Production of PAT-DX1 Next Quarter
|
|
salty74
|
62 |
14K |
9 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
62
|
14K
|
9
|
|
ASX - By Stock
|
PAB |
Re:
ADC's on the move........
|
|
salty74
|
9 |
2.8K |
3 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
9
|
2.8K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Notification of cessation of securities - PAB
|
|
salty74
|
21 |
4.8K |
1 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
21
|
4.8K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Chair's Address and CEO Presentation to 2023 AGM
|
|
salty74
|
74 |
27K |
9 |
26/11/23 |
26/11/23 |
ASX - By Stock
|
74
|
27K
|
9
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Chair's Address and CEO Presentation to 2023 AGM
|
|
salty74
|
74 |
27K |
6 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
74
|
27K
|
6
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Patrys Receives R&D Tax Incentive Refund
|
|
salty74
|
12 |
3.9K |
2 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
12
|
3.9K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Patrys Receives R&D Tax Incentive Refund
|
|
salty74
|
12 |
3.9K |
8 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
12
|
3.9K
|
8
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 30 September 2023
|
|
salty74
|
14 |
5.3K |
4 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
14
|
5.3K
|
4
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 30 September 2023
|
|
salty74
|
14 |
5.3K |
5 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
14
|
5.3K
|
5
|
|
ASX - By Stock
|
PAB Medicine |
Re:
GENETAL
|
|
salty74
|
74 |
35K |
4 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
74
|
35K
|
4
|
|
ASX - By Stock
|
PAB Medicine |
Re:
GENETAL
|
|
salty74
|
74 |
35K |
0 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
74
|
35K
|
0
|
|
ASX - By Stock
|
PAB Medicine |
Re:
GENETAL
|
|
salty74
|
74 |
35K |
3 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
74
|
35K
|
3
|
|
ASX - By Stock
|
PAB Medicine |
Re:
GENETAL
|
|
salty74
|
74 |
35K |
3 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
74
|
35K
|
3
|
|
ASX - By Stock
|
PAB Medicine |
Re:
GENETAL
|
|
salty74
|
74 |
35K |
4 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
74
|
35K
|
4
|
|
ASX - By Stock
|
PAB Medicine |
Re:
GENETAL
|
|
salty74
|
74 |
35K |
2 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
74
|
35K
|
2
|
|
ASX - By Stock
|
PAB Medicine |
Re:
GENETAL
|
|
salty74
|
74 |
35K |
1 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
74
|
35K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4E and 2023 Annual Report
|
|
salty74
|
21 |
10K |
4 |
19/09/23 |
19/09/23 |
ASX - By Stock
|
21
|
10K
|
4
|
|
ASX - By Stock
|
PAB |
1c Party
|
|
salty74
|
20 |
6.5K |
2 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
20
|
6.5K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4E and 2023 Annual Report
|
|
salty74
|
21 |
10K |
2 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
21
|
10K
|
2
|
|
ASX - By Stock
|
PAB Medicine |
Re:
GENETAL
|
|
salty74
|
74 |
35K |
3 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
74
|
35K
|
3
|
|
ASX - By Stock
|
PAB Medicine |
Re:
GENETAL
|
|
salty74
|
74 |
35K |
9 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
74
|
35K
|
9
|
|